In addition, different mutations in the same gene are not always effectively inhibited by the same targeted therapy, as has been observed in gastrointestinal stromal tumors with KIT mutations [45] and in lung cancer with EGFR mutations [46]. Here, EGFR is linked to lung carcinoma.